Methotrexate treatment and mortality in rheumatoid arthritis
Authors:
- 1 October 2002
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 360 (9339) , 1097
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsArthritis & Rheumatism, 2002
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Statins prevent endothelial cell activation induced by antiphospholipid (anti-?2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotypeArthritis & Rheumatism, 2001
- Oxidized Low-Density Lipoprotein and Autoimmune Antibodies in Patients With Antiphospholipid Syndrome With a History of ThrombosisAmerican Journal of Clinical Pathology, 2001
- IVIG-pools: regulatory giftsTransfusion and Apheresis Science, 2001